U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
6780167801XM-One Study for Living Donor ProgramRecruitingNo Results AvailableTransplant; Failure, Kidneyhttps://ClinicalTrials.gov/show/NCT01679184
6780267802One Year Outcome of Elderly Patients Admitted to an ICU and Mechanically VentilatedRecruitingNo Results AvailableElderly Carehttps://ClinicalTrials.gov/show/NCT01679171
6780367803MOTIVATE Weight Loss StudyCompletedNo Results AvailableObesityDevice: Using The IOP system from USGI to place suture anchorshttps://ClinicalTrials.gov/show/NCT01679158
6780467804Learning and Relapse Risk in Alcohol DependenceCompletedNo Results AvailableAlcohol Use Disordershttps://ClinicalTrials.gov/show/NCT01679145
6780567805CVRx Barostim Hypertension Pivotal TrialActive, not recruitingNo Results AvailableUncontrolled HypertensionDevice: Neo Baroreflex Activation Therapy Systemhttps://ClinicalTrials.gov/show/NCT01679132
6780667806Treatment of Patients With Diffuse Large B Cell Lymphoma Who Are Not Suitable for Anthracycline Containing ChemotherapyRecruitingNo Results AvailableDiffuse Large B Cell LymphomaDrug: Cyclophosphamide|Drug: Vincristine|Drug: Prednisolone|Drug: Rituximab|Drug: Inotuzumab Ozogamicin|Drug: Gemcitabinehttps://ClinicalTrials.gov/show/NCT01679119
6780767807The Effects of Continuous Transversus Abdominis Plane (TAP) Catheters on Postoperative Pain After Renal TransplantationActive, not recruitingNo Results AvailablePainOther: TAP catheter with Ropivicaine|Other: Fentanyl IV PCA and placebo TAP catheterhttps://ClinicalTrials.gov/show/NCT01679106
6780867808Antagonism Research Between Antiemetics Agents (Droperidol, Dexametasone, Ondansetron) and Acetaminophen in Thyroidectomy's Post-operative Analgesia.CompletedNo Results AvailableInteraction Between Antiemetic Drugs and ParacetamolDrug: ondansetron|Drug: Droperidol|Drug: Dexamethasonehttps://ClinicalTrials.gov/show/NCT01679093
6780967809The Effect of Treatment With Teriparatide and Zoledronic Acid in Patients With Osteogenesis ImperfectaRecruitingNo Results AvailableOsteogenesis ImperfectaDrug: Zoledronic acid|Drug: Teriparatide|Drug: placebo zoledronic acid|Drug: placebo teriparatidehttps://ClinicalTrials.gov/show/NCT01679080
6781067810Gut Associated Lymphatic Tissue (GALT) in HIV (Human Immunodeficiency Virus)- Infected PatientsRecruitingNo Results AvailableHIV InfectionProcedure: colonoscopy with endoscopic biopsieshttps://ClinicalTrials.gov/show/NCT01679067
6781167811Cost-minimization Analysis of Gastric Cancer Treatments in Hong KongCompletedNo Results AvailableGastric Cancerhttps://ClinicalTrials.gov/show/NCT01679054
6781267812High Dose Chemo With Stem Cell Transplant as Treatment for Multiple Sclerosis That Failed Prior TreatmentTerminatedNo Results AvailableMultiple SclerosisDrug: Alemtuzumab|Drug: Fludarabine|Drug: Cyclophosphamidehttps://ClinicalTrials.gov/show/NCT01679041
6781367813Dose-Escalate Study to Investigate the Safety and Tolerability of T89 in JapaneseCompletedHas ResultsHealthyDrug: T89 Group A|Drug: Placebo Group A|Drug: Placebo Group B|Drug: T89 Group B|Drug: Placebo Group C|Drug: T89 Group Chttps://ClinicalTrials.gov/show/NCT01679028
6781467814Evaluating Patients With Eye Allergies and Determining if There Are Also Dry EyesActive, not recruitingNo Results AvailableDry Eyes|Allergic Conjunctivitishttps://ClinicalTrials.gov/show/NCT01679015
6781567815Steady-state Pharmacokinetics of BIA 2-093 and Oxcarbazepine in Healthy VolunteersCompletedHas ResultsEpilepsyDrug: BIA 2-093|Drug: Oxcarbazepinehttps://ClinicalTrials.gov/show/NCT01679002
6781667816Evaluation of Brain MRI and Clinical Characteristics of Adolescents With Bipolar Disorder and Children of Parents With Bipolar DisorderRecruitingNo Results AvailableBipolar Disorderhttps://ClinicalTrials.gov/show/NCT01678989
6781767817Tolerability and Pharmacokinetics of a Single 900 mg Oral Dose of BIA 2-093 and Oxcarbazepine in Healthy VolunteersCompletedHas ResultsEpilepsyDrug: BIA 2-093|Drug: Oxcarbazepinehttps://ClinicalTrials.gov/show/NCT01678976
6781867818Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD)CompletedNo Results AvailableNeovascular Age Related Macular DegenerationDrug: Squalamine lactate|Drug: Vehicle controlhttps://ClinicalTrials.gov/show/NCT01678963
6781967819MostCare Versus Echo-Doppler for Cardiac Output MeasurementCompletedNo Results AvailableCardiac Output Measurementhttps://ClinicalTrials.gov/show/NCT01678950
6782067820Immune Tolerance and Alloreactivity in Liver Transplant Recipients on Different Monotherapy Immunosuppressive AgentsCompletedNo Results AvailableLiver Transplant Rejection|ImmunosuppressionProcedure: Blood Draw - Rapamycin|Procedure: Blood Draw from Control Subjects|Procedure: Blood Draw - CyA|Procedure: Blood Draw - Tacrolimus|Procedure: Blood Draw - MMF|Procedure: Blood Draw - Rapamycinhttps://ClinicalTrials.gov/show/NCT01678937
6782167821A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic NeuralgiaActive, not recruitingNo Results AvailableNeuralgia, PostherpeticDrug: AGN-214868|Drug: AGN-214868 Placebo (Vehicle)https://ClinicalTrials.gov/show/NCT01678924
6782267822Efficacy of Gralise® for Chronic Pelvic PainTerminatedHas ResultsIrritable Bowel Syndrome|Ulcerative Colitis|Interstitial Cystitis|Prostatitis|Pelvic PainDrug: Gralisehttps://ClinicalTrials.gov/show/NCT01678911
6782367823Dose-ranging Study of PRX-102 in Adult Fabry Disease PatientsRecruitingNo Results AvailableFabry DiseaseDrug: PRX-102https://ClinicalTrials.gov/show/NCT01678898
6782467824Assessment of Energy BalanceCompletedHas ResultsCaloric Intake and Energy MetabolismBehavioral: Digital Photography of Foods|Other: doubly labeled water|Device: IDEEA|Behavioral: low-calorie diethttps://ClinicalTrials.gov/show/NCT01678885
6782567825A Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular DegenerationEnrolling by invitationNo Results AvailableAge-Related Macular DegenerationDrug: RetinoStathttps://ClinicalTrials.gov/show/NCT01678872
6782667826Cervical Mucus - the Biochemical and Molecular Properties in Fertile and Subfertile Women (C-MIS Study)RecruitingNo Results AvailableInfertilityhttps://ClinicalTrials.gov/show/NCT01678859
6782767827Good Schools StudyActive, not recruitingNo Results AvailablePhysical Violence|Educational Achievement|Mental Health|Sexual Violence|Violence Against ChildrenBehavioral: Good School Toolkithttps://ClinicalTrials.gov/show/NCT01678846
6782867828Understanding Drug Abuse Treatment OutcomesRecruitingNo Results AvailableDrug Abuse/Dependencehttps://ClinicalTrials.gov/show/NCT01678833
6782967829A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-266)TerminatedHas ResultsType 2 Diabetes MellitusDrug: Sitagliptin/Simvastatin FDC|Drug: Sitagliptin|Drug: Simvastatin|Drug: Placebo to sitagliptin|Drug: Placebo to simvastatin|Drug: Placebo to Sitagliptin/Simvastatin FDC|Drug: Metformin|Drug: Glimepiridehttps://ClinicalTrials.gov/show/NCT01678820
6783067830Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)CompletedNo Results AvailableRhinitis, Allergic, Perennial|Rhinitis, Allergic, NonseasonalBiological: MK-8237 6 DU|Biological: MK-8237 12 DU|Biological: Placebohttps://ClinicalTrials.gov/show/NCT01678807

* Görseller ve İçerik tekif hakkına sahip olabilir